（Rituxan、Truxima）可能对某些使用其他药物无效的人有益。临床试验显示， 伏环孢素可以有效治疗狼疮。 今年流感季到来前，红斑狼疮病人有无必要 ...

The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.

10 月 23 日，罗氏公布三季度报， 前九个月，制药业务销售额 343 亿瑞士法郎，增长 7%，基础业务 （不包括 COVID-19）增长 9%；第三季度，实现销售额增长 9% （以瑞士法郎计算为 6%），与第二季度持平。

It looks increasingly likely that Roche’s cancer blockbuster Rituxan (rituximab) will face competition from a cheaper biosimilar in the coming months after backing from an FDA expert committee.

Though we’ve recently observed some improvement in U.S. biosimilar penetration, market entry and uptake still consistently ...

A range of medications are available to help treat lupus nephritis (LN), each offering a specific role in managing the ...

罗氏的三驾马车贝伐珠单抗(Avastin)、利妥昔单抗(Rituxan)和曲妥珠单抗(Herceptin)，23年销售额合计不足45亿瑞士法郎，较巅峰时期缩量近80%。 虽然从现有 ...

Regulatory Approvals and Drug Innovations: The approval of novel drugs for blood cancer treatment, such as Imbruvica, Rituxan, and Glivec, plays a pivotal role in the market’s growth. Collaborations ...

or the B-cell-depleting agent rituximab (Rituxan, Genentech, Inc. and Biogen Idec) in combination with the immunosuppressive drug methotrexate to treat rheumatoid arthritis that is resistant to ...

Three other biologics for RA that have alternative mechanisms of action have been approved in the United States and elsewhere: anakinra (Kineret; Amgen), rituximab (Rituxan; Biogen–Idec/Roche ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 ...

Moreover, high-efficacy monoclonal antibody therapy -- ocrelizumab (Ocrevus), rituximab (Rituxan), or natalizumab (Tysabri) - ...